Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies

Virology

Volumn 223, Issue 1, 1996, Pages 174-184

  Christensen, Neil D ^a   Dillner, Joakim ^b   Eklund, Carina ^b   Carter, Joseph J ^c   Wipf, Gregory C ^c   Reed, Cynthia A ^a   Cladel, Nancy M ^a   Galloway, Denise A ^c  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; SYNTHETIC PEPTIDE;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; VIRUS NEUTRALIZATION; VIRUS PARTICLE;

EID: 0030245737     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0466     Document Type: Article

References (45)

1. Beiss, B. K., Heimer, E., Felix, A., Burk, R. D., Ritter, D. B., Mallon, R. G., and Kadish, A. S. (1991). Type-specific and cross-reactive epitopes in human papillomavirus type 16 capsid proteins. Virology 184, 460-464.
2. Bernard, H.-U., Chan, S.-Y., and Delius, H. (1994). Evolution of papillomaviruses. Curr. Top. Microbiol. Immunol. 186, 33-54.
3. Bosch, F. X., Manos, M. M., Muñoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shah, K. V., and the IBSCC Study Group. (1995). Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J. Natl. Cancer Inst. 87, 796-802.
4. Brandsma, J. L., Brownstein, D. G., Xiao, W., and Longley, B. J. (1995). Papilloma formation in human foreskin xenografts after inoculation of human papillomavirus type 16 DNA. J. Virol. 69, 2716-2719.
5. Breitburd, F., Kirnbauer, R., Hubbert, N. L., Nonnenmacher, B., Trin-Dinh-Desmarquet, C., Orth, G., Schiller, J. T., and Lowy, D. R. (1995). Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69, 3959-3963.
6. Cason, J., Patel, D., Naylor, J., Lunney, D., Shepherd, P. S., Best, J. M., and McCance, D. J. (1989). Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes. J. Gen. Virol. 70, 2973-2987.
7. Cason, J., Kambo, P. K., Best, J.M., and McCance, D. J. (1992). Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children. Int. J. Cancer 50, 349-355.
8. Chan, S.-Y., Bernard, H.-U., Ong, C.-K., Chan, S.-P., Hofmann, B., and Delius, H. (1992). Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: A showcase for the molecular evolution of DNA viruses. J. Virol. 66, 5714-5725.
9. Christensen, N. D., and Kreider, J. W. (1991). Neutralization of CRPV infectivity by monoclonal antibodies that identify conformational epitopes on intact virions. Virus Res. 21, 169-179.
10. Christensen, N. D., Kreider, J. W., Cladel, N. M., Patrick, S. D., and Welsh, P. A. (1990). Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. J. Virol. 64, 5678-5681.
11. Christensen, N. D., Höpfl, R., DiAngelo, S. L., Cladel, N. M., Patrick, S. D., Welsh, P. A., Budgeon, L. R., Reed, C. A., and Kreider, J. W. (1994a). Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. J. Gen. Virol. 75, 2271-2276.
12. Christensen, N. D., Kirnbauer, R., Schiller, J. T., Ghim, S.-J., Schlegel, R., and Kreider, J. W. (1994b). Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology 205, 329-335.
13. Cowsert, L. M., Lake, P., and Jenson, A. B. (1987). Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies. J. Natl. Cancer Inst. 79, 1053-1058.
14. Cubie, H. A. (1974). Experiments with human papilloma virus in cell culture. Br. J. Dermatol. 91, 569-571.
15. Devilliers, E. M. (1989). Papilloma viruses in cancers and papillomas of the aerodigestive tract. Biomed. Pharmacother. 43, 31-36.
16. Dillner, J., Dillner, L., Utter, G., Eklund, C., Rotola, A., Costa, S., and DiLuca, D. (1990). Mapping of linear epitopes of human papillomavirus type 16: The L1 and L2 open reading frames. Int. J. Cancer 45, 529-535.
17. Dollard, S. C., Wilson, J. L., Demeter, L. M., Bonnez, W., Reichman, R. C., Broker, T. R., and Chow, L. T. (1992). Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. Genes Dev. 6, 1131-1142.
18. Eklund, C., and Dillner, J. (1995). A two-site enzyme immunoassay for quantitation of human papillomavirus type 16 particles. J. Virol. Methods 53, 11-23.
19. Favre, M., Breitburd, F., Croissant, O., and Orth, G. (1975). Structural polypeptides of rabbit, bovine and human papillomaviruses. J. Virol. 15, 1239-1247.
20. Hagensee, M. E., Yaegashi, N., and Galloway, D. A. (1993). Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67, 315-322.
21. Hagensee, M. E., Olson, N. H., Baker, T. S., and Galloway, D. A. (1994). Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. J. Virol. 68, 4503-4505.
22. Heino, P., Dillner, J., and Schwartz, S. (1995a). Human papillomavirus type 16 capsid proteins produced from recombinant Semliki forest virus assemble into virus-like particles. Virology 214, 349-359.
23. Heino, P., Skyldberg, B., Lehtinen, M., Rantala, I., Hagmar, B., Kreider, J. W., Kirnbauer, R., and Dillner, J. (1995b). Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes. J. Gen. Virol. 76, 1141-1153.
24. Jenison, S. A., Yu, X.-P., Valentine, J. M., and Galloway, D. A. (1991). Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18. J. Virol. 65, 1208-1218.
25. Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R., and Schiller, J. T. (1992). Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89, 12180-12184.
26. Kreider, J. W., Howett, M. K., Wolfe, S. A., Bartlett, G. L., Zaino, R. J., Sedlacek, T. V., and Mortel, R. (1985). Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata. Nature 317, 639-641.
27. Kreider, J. W., Patrick, S. D., Cladel, N. M., and Welsh, P. A. (1990). Experimental infection with human papillomavirus type 1 of human hand and foot skin. Virology 177, 415-417.
28. Majewski, S., Breitburd, F., Skopinska, M., Croissant, O., Jablonska S., and Orth, G. (1994). A mouse model for studying epidermodysplasia-verruciformis-associated carcinogenesis. Int. J. Cancer 56, 727-730.
29. McLean, C. S., Churcher, M. J., Meinke, J., Smith, G. L., Higgins, G., Stanley, A., and Minson, A. C. (1990). Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. J. Clin. Pathol. 43, 488-492.
30. Meyers, C., Frattini, M. G., Hudson, J. B., and Laimins, L. A. (1992). Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257, 971-973.
31. Müller, M., Gissmann, L., Cristiano, R. J., Sun, X.-Y., Frazer, I. H., Jenson, A. B., Alonso, A., Zentgraf, H., and Zhou, J. (1995). Papillomavirus capsid binding and uptake by cells from different tissues and species. J. Virol. 69, 948-954.
32. Roden, R. B. S., Kirnbauer, R., Jenson, A. B., Lowy, D. R., and Schiller, J. T. (1994a). Interaction of papillomaviruses with the cell surface. J. Virol. 68, 7260-7266.
33. Roden, R. B. S., Weissinger, E. M., Henderson, D. W., Booy, F., Kirnbauer, R., Mushinski, J. F., Lowy, D. R., and Schiller, J. T. (1994b). Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J. Virol. 68, 7570-7574.
34. Roden, R. B. S., Hubbert, N. L., Kirnbauer, R., Breitburd, F., Lowy, D. R., and Schiller, J. T. (1995). Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor. J. Virol. 69, 5147-5151.
35. Roden, R. B. S., Hubbert, N. L., Kirnbauer, R., Christensen, N. D., Lowy, D. R., and Schiller, J. T. (1996). Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J. Virol. 70, 3298-3301.
36. Rose, R. C., Reichman, R. C., and Bonnez, W. (1994). Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. J. Gen. Virol. 75, 2075-2079.
37. Sasagawa, T., Pushko, P., Steers, G., Gschmeissner, S. E., Hajibagheri, M. A., Finch, J., Crawford, L., and Tommasino, M. (1995). Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology 206, 116.
38. Seedorf, K., Krammer, G., Durst, M., Suhai, S., and Rowekamp, W. G. (1985). Human papillomavirus type 16 DNA sequence. Virology 145, 181-185.
39. Sterling, J., Stanley, M., Gatward, G., and Minson, T. (1990). Production of human papillomavirus type 16 virions in a keratinocyte cell line. J. Virol. 64, 6305-6307.
40. Taichman, L. B., Breitburd, F., Croissant, O., and Orth, G. (1984). The search for a culture system for papillomaviruses. J. Invest. Dermatol. 83, 2s-6s.
41. Volpers, C., Schirmacher, P., Streeck, R. E., and Sapp, M. (1994). Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology 200, 504.
42. Volpers, C., Unckell, F., Schirmacher, P., Streeck, R. E., and Sapp, M. (1995). Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J. Virol. 69, 3258-3264.
43. Zhou, J., Sun, X. Y., Stenzel, D. J., and Frazer, I. H. (1991). Expression of vaccinia recombinant HPV-16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185, 251-257.
44. Zhou, J., Sun, X.-Y., Davies, H., Crawford, L., Park, D., and Frazer, I. H. (1992). Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles. Virology 189, 592-599.
45. zur Hausen, H. (1991). Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184, 9-13.